Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000861108 | SCV000534241 | likely benign | not provided | 2018-10-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001002454 | SCV001001331 | benign | Charcot-Marie-Tooth disease dominant intermediate C | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000861108 | SCV001146658 | benign | not provided | 2019-01-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002454 | SCV001160396 | likely benign | Charcot-Marie-Tooth disease dominant intermediate C | 2018-07-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002461182 | SCV002754907 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |